Latest News

AVI Bio Pharma is a leader in RNA based technology, the company is developing a range of potential therapeutic compounds that target different types of RNA. Unlike most other RNA-based approaches, AVI’s technology has been used to directly target both messenger RNA (mRNA) and precursor messenger RNA (pre-mRNA) to either down-regulate or up-regulate targeted genes or proteins.

This Bio-pharmaceutical company has several drugs in the pipeline, and strategic alliances with leading institutions and pharmaceutical firms. The company also has collaborative agreements with select academic, governmental and non-governmental organizations. Very Attractive, Medium to Long Term, Bouncing Back from 52WK Lows.

You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®

we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks